The first group of volunteer soldiers is preparing for the start of clinical trials of the domestic vaccine from COVID-19, developed by the Ministry of Defense and the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei, according to the press service of the military department.
Some of the volunteers have already arrived at a special institution for medical examination before the experiment.
The subjects were searched among the military, contract employees, noted in the military department. At this stage, 50 people were selected to participate in the experiment, among them five women, as well as ten medical workers, including doctors.
Previously, the vaccine was tested for toxicity, safety and protective efficacy in large and small animals. After the introduction of the vaccine, they developed full-fledged immunity to the virus, said the head of the 48th Central Research Institute of the Russian Ministry of Defense, Colonel of the Medical Service Sergey Borisevich. It is at this institute that tests will be held. They, according to the Ministry of Defense, will end in July.
On the basis of the 48th Central Research Institute of the Ministry of Defense of the Russian Federation, the safety, immunogenicity and protective efficacy of genetic engineering vaccines for Ebola hemorrhagic fever, Middle East respiratory syndrome and universal influenza vaccine have already been studied and successfully tested.